Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.
USOR 23243 - Ph2 Randomized dose-optimization study of alisertib in patients with SCLC (PB-8237)
A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)
Disease Types: Lung - Small Cell Lung
Available at: Arlington Heights, Niles